Role of caffeine in combined analgesic drugs from the paint of view of experimental pharmacology

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 8, 1997, Pages 917-927

  Engelhardt, Günther ^a   Mauz, Annerose B ^a   Pairet, Michel ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Acetylsalicylic acid; Aminophenazone; Caffeine; CAS 103 90 2; CAS 50 78 2; CAS 58 08 2; CAS 58 15 1; Paracetamol; Pharmacodynamic interaction; Pharmacokinetic interaction; Toxicological interaction

Indexed keywords

ACETYLSALICYLIC ACID; AMINOPHENAZONE; CAFFEINE; CODEINE; DICLOFENAC; DIPYRONE; PARACETAMOL; PHENAZONE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; INFLAMMATION; LIVER TOXICITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PAW EDEMA; PROSTAGLANDIN SYNTHESIS; RAT;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BRAIN CHEMISTRY; CAFFEINE; CATTLE; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG COMBINATIONS; ELECTRIC STIMULATION; ENZYMES; INFLAMMATION; LIVER; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; PAIN MEASUREMENT; PHYSICAL STIMULATION; PROSTAGLANDINS; RATS; RATS, INBRED STRAINS; STOMACH ULCER;

EID: 0030740655     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. Astrup, A., Toubro, S., Cannon, S., Am. J. Clin. Nutr. 51, 759 (1990)
2. Barraco, R. A., Coffin, V. L., Altman, H. J. et al., Brain Res. 272, 392 (1983)
3. Bleehen, T., Keele, C. A., Pain 3, 367 (1977)
4. Bosse, K., Kühner, A., Therapiewoche 38, 3879 (1988)
5. Bundesgesundheitsamt (BGA), Paracetamol plus Coffein in fixer Kombination. Monographie der Aufbereitungskommission B-3, "Neurologie/Psychiatrie", Bundesanzeiger Nr. 209 (1988)
6. Bundesgesundheitsamt (BGA), Acetylsalicylsäure plus Coffein in fixer Kombination. Monographie der Aufbereitungskommission B-3, "Neurologie/Psychiatrie", Bundesanzeiger Nr. 31 (1994)
7. Camann, W. R., Murray, R. S., Mushlin, P. S. et al., Anaesth. Analg. 70, 181 (1990)
8. Chen, Y. P., Beckman, H. A., Science 113, 631 (1951)
9. Cronstein, B. N., J. Appl. Physiol. 76, 5 (1994)
10. Dahanukar, S. A., Pohujani, S., Shet, U. K., Indian. J. Med. Res. 68, 844 (1978)
11. De Lander, G. E., Hopkins, C. J., J. Pharmacol. Exp. Ther. 239, 88 (1986)
12. Doak, G. I., Sawynok, J., Eur. J. Pharmacol. 281, 311 (1995)
13. Doepfner, W., Cerletti, A., Int. Arch. Allergy Appl. Immunol. 12, 90 (1958)
14. Domenjoz, R., Ann. N. Y., Acad. Sci. 86, 263 (1960)
15. Eichholtz, F., Kullmann, F., Naunyn-Schmiedeberg's Arch. Exp. Path. Pharmakol. 184, 612 (1937)
16. Ellman, G. L., Arch. Biochem. Biophys. 82, 70 (1959)
17. Elseviers, M. M., De Broe, M. E., Nephrol. Dial. Transplant. 9, 41 (1994)
18. Engelhardt, G., Ärztl. Forsch. 30, 1 (1983)
19. Engelhardt, G., Arzneim.-Forsch./Drug Res. 34 (I), 992 (1984)
20. Engelhardt, G., Arzneim.-Forsch./Drug Res. 46 (I), 509 (1996)
21. Engelhardt, G., Homma, D., Arzneim.-Forsch./Drug Res. 46 (I), 513 (1996)
22. Fialip, J., Porteix, A., Marty, H. et al., Arch. Int. Pharmacodyn. 302, 86 (1989)
23. Fieller, E. C., Quart. J. Pharm. Pharmacol. 17, 117 (1944)
24. Finn. L. B., Holtzman, S. G., Psychopharmacology 93, 428 (1987)
25. Finney, D. J., Probit analysis, 3rd ed., Cambridge University Press, Cambridge (1971)
26. Flower, J. R., Cheung, H. S., Cushman, D. W., Prostaglandins 4, 325 (1973)
27. Forbes, J. A., Beaver, W. T., Jones, K. F., Clin. Pharmacol. Ther. 49, 674 (1991)
28. Fox, J. M., Pharm. Z. 141, 4376 (1996)
29. Fredholm, B. B., in: The Methylxantine Baverages and Foods: Chemistry, Consumption, and health Effects, G. A. Spiller (ed.), pp. 303-330, Alan R. Liss, New York (1984)
30. Fredholm, B. B., Abbracchio, M. P., Burnstock, G. et al., Pharmacol. Rev. 46, 143 (1994)
31. Friebel, H., Sommer, S., Varadan, K. S., Arzneim.-Forsch./Drug Res. 9, 126 (1959)
32. Fuchs, H. R., Giertz, H., Arzneim.-Forsch./Drug Res. 10, 526 (1960)
33. Giertz, H., Goebels, H., Rummel, W., Arch. Exp. Path. Pharmakol. 229, 26 (1956)
34. Giertz, H., Jurna, I., Naturwissenschaften 44, 445 (1957)
35. Gomahr, H., Arzneim.-Forsch./Drug Res. 6, 663 (1956)
36. Grupp, G., Grupp, M., v. Hattingberg, I., Arzneim.-Forsch./Drug Res. 2, 211 (1952)
37. Haffner, F., Dtsch. Med. Wschr. 54, 731 (1929)
38. Hartung, R., Heyne, A., Arch. Pharmacol. 349 (Suppl.), R98 (1994)
39. Kaplan, G. B., Greenblatt, D. J., Kent, M. A. et al., Neuropsychopharmacology 6, 145 (1992)
40. Karlsten, R., Gordh, I., Hartvig, P. et al., Anaesth. Analg. 71, 60 (1990)
41. Karlsten, R., Gordh, T., Post, C., Pharmacol. Toxicol. 70, 434 (1992)
42. Karlsten, R., Post, C., Hide, I. et al., Neurosci. Lett. 121, 267 (1991)
43. Katims, J. J., Annau, Z., Snyder, S. H., J. Pharmacol. Exp. Ther. 227, 167 (1983)
44. Klupp, H., Kähling, J., Arzneim.-Forsch./Drug Res. 15, 359 (1965)
45. Laska, E. M., Sunshine, A., Mueller, F. et al., J. Am. Med. Assoc. 251, 1711 (1984)
46. Lee, C. A., Lillibridge, J. H., Nelson, S. D. et al., J. Pharmacol. Exp. Ther. 277, 287 (1996)
47. Linder, A., Statistische Methoden, 4th ed., pp. 148-162, Birkhäuser, Basel (1964)
48. Lippert, T. H., Samaha, M., Arzneim.-Forsch./Drug Res. 15, 1079 (1965)
49. Lock, F. M., de Vries, J., Mullink, H. et al., Pharm. Weekbl. Sci. Ed. 4, 211 (1982)
50. Malec, D., Michalska, E. et al., Pol. J. Pharmacol. Pharm. 40, 223 (1988)
51. Malmberg, A. B., Yaksh, T. L., Anesthesiology 79, 270 (1993)
52. Mathew, R. J., Barr, D. L., Weinman, L., Br. J. Psychiatry 143, 604 (1983)
53. Migliardi, J. R., Armellino, J. J., Friedman, M. et al., Clin. Pharmacol. Ther. 56, 576 (1994)
54. Nehlig, A., Darval, J. L., Debry, G., Brain Res. Rev. 17, 139 (1992)
55. Ogilvie, R. L., Fernandez, P. G., Winsberg, F., Eur. J. Clin. Pharmacol. 12, 409 (1977)
56. Person, D. L., Kissin, I., Brown, P. T. et al., Anaesth. Analg. 64, 851 (1985)
57. Pommer, W., Bronder, E., Greiser, E. et al., Am. J. Nephrol. 9,403 (1989)
58. Pommer, W., Bronder, E., Klimpel, A. et al., Lancet I, 381 (1989)
59. Poon, A., Sawynok, J., Eur. J. Pharmacol. 286, 177 (1995)
60. Post, C., Neurosci. Lett. 51, 325 (1984)
61. Randall, L. O., Selitto, J. J., Arch. Int. Pharmacodyn. 111, 409 (1957)
62. De Beer, R., cited after Burn: Biological Standardization, Oxford (1952)
63. Sato, C., Izumi, N., Nouchi, T. et al., Toxicology 34, 95 (1985)
64. Sawynok, J., Drugs 49, 37 (1995)
65. Sawynok, J., Reid, A., Eur. J. Pharmacol. 298, 105 (1996)
66. Sawynok, J., Reid, A., Pharmacol. Exp. Therap. 277, 646 (1996)
67. Sawynok, J., Reid, A. R., Doak, G. J., Pain 61, 203 (1995)
68. Sawynok, J., Yaksh, I. L., Pharmacol. Rev. 45, 43 (1993)
69. Schachtel, B. P., Fillingin, J. M., Lane, A. C. et al., Arch. Int. Med. 151, 733 (1991)
70. Schmid, J., Brickl, R., in: Zur Problematik der schwachwirksamen Analgetika, W. Forth (ed.), pp. 121-130, G. Braun, Stuttgart (1986)
71. Seegers, A. J. M., Jager, L. P., van Noordwijk, J., J. Pharm. Pharmacol. 31, 840 (1979)
72. Seegers, A. J. M., Jager, L. P., van Noordwijk, J., Prostaglandin Thromboxane Res. 8, 1547 (1980)
73. Seegers, A. J. M., Jager, L. P., Zandberg, P. et al., Arch. Int. Pharmacodyn. 251, 237 (1981)
74. Siegers, C. P., Pharmacology 10, 19 (1973)
75. Snyder, S. H., Katims, J. J., Annau, Z. et al., Proc. Natl. Acad. Sci. USA 78, 3260 (1981)
76. Taiwo, Y. O., Levine, J. D., Neuroscience 38, 756 (1990)
77. Takeuchi, K., Kogo, H., Aizawa, Y., Japn. J. Pharmacol. 31, 253 (1981)
78. Tukker, J. J., Sitsen, J. M. A., Gusdorf, C. F., Pharm. Weekbl. Sci. Ed. 8, 239 (1986)
79. Vinegar, R., Truax, J. F., Selph, J. L. et al., Proc. Soc. Exp. Biol. Med. 151, 556 (1976)
80. Vorstände der Deutschen Gesellschaft für Nephrologie und der Arbeitsgemeinschaft für Klinische Nephrologie: Erklärung zur Neophrotoxizität von Analgetika-Kombinationen, Berlin, 22. September 1996 -
81. Ward, N., Whiteny, C., Avery, D. et al., 44, 151 (1991)
82. Weigmann, R., Flemming, J., Arzneim.-Forsch./Drug Res. 3, 606 (1953)
83. White, H. L., Glassman, J., Prostaglandins 7, 123 (1974)
84. Whitehouse, L. W., Paul, C. J., Thomas, B. H., Toxicol. Appl. Pharmacol. 38, 571 (1976)
85. Williams, M. W., Toxicol. Appl. Pharmacol. 1, 447 (1959)
86. Winter, Ch. A., Risley, E. A., Nuss, G. W., Proc. Soc. Exp. Biol. Med. 111, 544 (1962)
87. Winter, L., Appleby, F., Ciccone, P. E. et al., Curr. Ther. Res. 33, 115 (1983)
88. Yoovathaworn, K. C., Sriwatanakul, K., Thithapandha, A., Eur. J. Drug Metabol. Pharmacokin. 11, 71 (1986)